PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för taurolidine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

28 hits

Bibliografisk träff 2024-04-11

Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.

Demirok A, Illy DHC, Nagelkerke SQ, Lagerweij MF, Benninga MA, Tabbers MM.

JPEN J Parenter Enteral Nutr · journal article · DOI 10.1002/jpen.2630

Bibliografisk träff 2024-02-29

The effect of taurolidine on the time-to-positivity of blood cultures.

van den Bosch CH, Moree JEP, Peeters S, Lankheet M, van der Steeg AFW, Wijnen MHWA, van de Wetering MD, van der Bruggen JT.

Infect Prev Pract · research-article; journal article · DOI 10.1016/j.infpip.2024.100352

Bibliografisk träff 2023-12-31

Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition.

Williams TJ, Moy N, Kaazan P, Callaghan G, Holtmann G, Martin N.

JPEN J Parenter Enteral Nutr · journal article · DOI 10.1002/jpen.2589

Bibliografisk träff 2023-12-01

Correction to: Taurolidine: could this be the 'silver bullet' against cardiac implantable electronic device infection?

Författaruppgift saknas

Europace · published erratum; correction · DOI 10.1093/europace/euad360

Bibliografisk träff 2023-11-14

Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study.

Savarese I, Yazami S, De Rose DU, Carkeek K, Campi F, Auriti C, Danhaive O, Piersigilli F.

J Hosp Infect · randomized controlled trial; journal article · DOI 10.1016/j.jhin.2023.11.003

Bibliografisk träff 2023-11-01

Taurolidine: could this be the 'silver bullet' against cardiac implantable electronic device infection?

Love CJ.

Europace · comment; editorial · DOI 10.1093/europace/euad332

Bibliografisk träff 2023-10-01

Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection.

Borov S, Baldauf B, Henke J, Pavaci H, Perani A, Zrenner B, Dietl J, Mehilli J, Lau EW, Vonthein R, Bonnemeier H.

Europace · research-article; journal article; observational study · DOI 10.1093/europace/euad306

Bibliografisk träff 2023-09-06

Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.

Agarwal AK, Roy-Chaudhury P, Mounts P, Hurlburt E, Pfaffle A, Poggio EC.

Clin J Am Soc Nephrol · clinical trial, phase iii; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.2215/cjn.0000000000000278

Bibliografisk träff 2023-08-10

Cost-utility analysis of 4% tetrasodium ethylenediaminetetraacetic acid, taurolidine, and heparin lock to prevent central line-associated bloodstream infections in children with intestinal failure.

Gattini D, Yan H, Belza C, Avitzur Y, Wales PW.

JPEN J Parenter Enteral Nutr · journal article · DOI 10.1002/jpen.2551

Bibliografisk träff 2023-06-04

In vitro comparison of the effectiveness of various antimicrobial locks with taurolidine in the treatment and prevention of catheter-related bloodstream infections in patients receiving parenteral nutrition.

Visek J, Ryskova L, Machacova A, Marikova M, Blaha V.

Nutrition · research support, non-u.s. gov't; journal article · DOI 10.1016/j.nut.2023.112115

Bibliografisk träff 2023-05-19

The effect of intraoperative immersion solutions on acellular dermal matrix: Biofilm formation and mechanical property.

Min K, Kim EK, Han HH, Eom JS.

J Plast Reconstr Aesthet Surg · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bjps.2023.05.025

Bibliografisk träff 2023-04-19

Use of Taurolidine in a Patient With a Cardiac Implantable Electronic Device Protrusion.

Giudice M, Catuzzo B, Berlier N, Lau EW, Bonnemeier H, Assadian O, Baldauf B, Borov S, Scacciatella P.

JACC Case Rep · journal article; case reports; case-report · DOI 10.1016/j.jaccas.2023.101835

Bibliografisk träff 2023-02-01

Treatment of long-term catheter-related bloodstream infections with short-course Daptomycin lock and systemic therapy associated with Taurolidine-lock: A multicenter experience.

Vassallo M, Denis E, Manni S, Lotte L, Fauque P, Sindt A.

J Vasc Access · multicenter study; journal article · DOI 10.1177/11297298231152500

Bibliografisk träff 2022-10-11

Is Vancomycin More Effective than Taurolidine? Comparative Analysis of Their Preventive Effect against Spinal Infection in 1000 Patients with Spinal Fusion.

Eun DC, Suk KS, Kim HS, Kwon JW, Moon SH, Lee YH, Lee BH.

Antibiotics (Basel) · research-article; journal article · DOI 10.3390/antibiotics11101388

Bibliografisk träff 2022-09-01

The Antiseptic and Antineoplastic Agent Taurolidine Modulates Key Leukocyte Functions.

Wouters Y, Mennen GRH, Te Morsche RHM, Roelofs HMJ, Wanten GJA.

In Vivo · research-article; journal article · DOI 10.21873/invivo.12933

Bibliografisk träff 2022-09-01

Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D.

Fontseré N, Soriano A, Mestres G, Bermudez P, Zarco F, Lozano V, Rodas L, Broseta J, Arias M, Maduell F.

Nefrologia (Engl Ed) · letter · DOI 10.1016/j.nefroe.2021.02.013

Bibliografisk träff 2022-07-31

Taurolidine-related adverse events in patients on home parenteral nutrition frequently indicate catheter-related problems.

Korzilius JW, Gillis VELM, Wouters Y, Wanten GJA.

Clin Nutr · research support, non-u.s. gov't; journal article · DOI 10.1016/j.clnu.2022.07.025

Bibliografisk träff 2022-07-15

Taurolidine Versus Ethanol Central Line Locks for Children on Parenteral Nutrition.

Vernon-Roberts A, Lopez RN, Day AS.

J Pediatr Gastroenterol Nutr · letter; comment · DOI 10.1097/mpg.0000000000003565

Bibliografisk träff 2022-06-13

Exploring the potential of taurolidine in inducing mobilization and detachment of colon cancer cells: a preliminary in-vitro study.

Mikolajczyk A, Khosrawipour V, Lau H, Li S, Migdal P, Labbé MK, Kielan W, Nicpon J, Stieglitz S, Khosrawipour T.

BMC Pharmacol Toxicol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s40360-022-00572-8

Bibliografisk träff 2022-03-25

Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.

Vernon-Roberts A, Lopez RN, Frampton CM, Day AS.

JPEN J Parenter Enteral Nutr · meta-analysis; research-article; journal article · DOI 10.1002/jpen.2363

Bibliografisk träff 2022-03-01

Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates.

Jafarian H, Amanati A, Badiee P.

Curr Med Mycol · research-article; journal article · DOI 10.18502/cmm.8.1.9211

Bibliografisk träff 2022-01-10

Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine.

Weichsel J, Baldauf B, Bonnemeier H, Lau EW, Dittrich S, Cesnjevar R.

J Cardiovasc Dev Dis · journal article; case reports; case-report · DOI 10.3390/jcdd9010018

Bibliografisk träff 2021-06-30

Does taurolidine have any effect on liver regeneration and oxidation in the experimental hepatectomy model?

Akın E, Sarıbeyoğlu K, Esen E, Aytaç E, Özbay G, Uzun H, Pekmezci S.

Turk J Surg · research-article; journal article · DOI 10.47717/turkjsurg.2021.4690

Bibliografisk träff 2021-05-22

Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D.

Fontseré N, Soriano A, Mestres G, Bermudez P, Zarco F, Lozano V, Rodas L, Broseta J, Arias M, Maduell F.

Nefrologia (Engl Ed) · letter · DOI 10.1016/j.nefro.2021.02.004

Bibliografisk träff 2021-02-01

[Taurolidine for the prevention of catheter-related infections in children with intestinal insufficiency: preliminary experience in a Chilean tertiary hospital].

Jordán P M, Haro C, Puchi A.

Rev Chilena Infectol · journal article · DOI 10.4067/s0716-10182021000100015

Bibliografisk träff 2019-08-01

[Taurolidine, an antiseptic for the prevention of central venous catheter-related infections].

Haro C.

Rev Chilena Infectol · review; journal article · DOI 10.4067/s0716-10182019000400414

Bibliografisk träff 2019-07-02

Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.

Swift L, Zhang C, Kovalchuk O, Boklan J, Trippett T, Narendran A.

Invest New Drugs · research support, non-u.s. gov't; journal article · DOI 10.1007/s10637-019-00816-1

Bibliografisk träff 2019-06-15

Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients.

Klimek K, Aresté Fosalba N, Ramírez López MÁ, Gómez Castilla AC, Salgueira Lazo M.

Nefrologia (Engl Ed) · journal article; case reports · DOI 10.1016/j.nefro.2019.03.014